The Food and Drug Administration has taken issue with health claims made by Cheerios, America’s best-selling breakfast cereal, signalling a new approach to food industry marketing under the Obama administration.

The FDA warned General Mills that it was, in effect, marketing its Cheerios breakfast cereal as a drug, because the cereal’s familiar yellow boxes carry unapproved claims about lowering cholesterol and reducing the risks of heart disease.